# Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

> **NCT03564405** · NA · COMPLETED · sponsor: **Jeil Pharmaceutical Co., Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Hepatocellular Carcinoma Non-resectable

## Interventions

- **DEVICE:** UNI-DEB

## Key facts

- **NCT ID:** NCT03564405
- **Lead sponsor:** Jeil Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-05
- **Primary completion:** 2017-03-07
- **Final completion:** 2017-05-17
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03564405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03564405, "Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT03564405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*